SAR

8 registered clinical trials studyying SAR — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR) NCT07459556	Chengdu Kangnuoxing Biopharma,Inc.	—
Not Yet Recruiting	A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Se NCT07146126	Prime Gene Therapeutics Co., Ltd.	Phase 3
Unknown	(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infect NCT04777981	Anewsha Therapeutics Inc.	N/A
Terminated	CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas NCT05128786	Shanghai PerHum Therapeutics Co., Ltd.	Phase 1
Completed	Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients NCT04535856	Ina-Respond	Phase 1
Completed	Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19. NCT04621058	Bioaraba Health Research Institute	Phase 3
Completed	Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Aller NCT01307319	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 3
Completed	Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of NCT02932774	Johnson & Johnson Consumer and Personal Products Worldwide	Phase 4